Speaking with investors and reporters, officials from Zimmer Holdings, Boston Scientific and Advanced Medical Technology Association, the industry trade group, said they opposed the proposal, which has not yet been written into legislation.
Ray Elliott, president and CEO of Boston Scientific, warned that the fees could lead to job cuts, reduced research and development, and moving company registrations offshore.
Read CNN Money’s report on proposed medical device company fees.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
